-
公开(公告)号:US20090104126A1
公开(公告)日:2009-04-23
申请号:US12253730
申请日:2008-10-17
申请人: Uwe SCHOEN , Harald Waldeck , Uwe Reinecker , Peter-Colin Gregory , Dania Reiche , Holger Sann , Michael Wurl , Jochen Antel
发明人: Uwe SCHOEN , Harald Waldeck , Uwe Reinecker , Peter-Colin Gregory , Dania Reiche , Holger Sann , Michael Wurl , Jochen Antel
IPC分类号: A61K9/12 , C07C307/02 , A61K31/255
CPC分类号: A61K9/0095 , A61K9/0019 , A61K9/02 , A61K9/2054 , A61K9/4866 , A61K47/10 , A61K47/26 , A61K47/38 , C07B2200/07 , C07C307/02 , C07C2602/42
摘要: A sulfamate compound corresponding to Formula I wherein R1 to R3 and n have defined meanings, pharmaceutical compositions comprising these compounds; a process for preparing these compounds, and the use of such compounds or compositions to treat or inhibit various disorders or disease states in patients in need thereof by administering to such a patient a therapeutically effective amount of such a compound.
摘要翻译: 对应于式I的氨基磺酸酯化合物,其中R 1至R 3和n具有定义的含义,包含这些化合物的药物组合物; 制备这些化合物的方法,以及使用这些化合物或组合物通过向这样的患者施用治疗有效量的这种化合物来治疗或抑制有需要的患者的各种疾病或疾病状态。